Heumos, Lukas http://orcid.org/0000-0002-8937-3457
Schaar, Anna C. http://orcid.org/0000-0003-1063-005X
Lance, Christopher http://orcid.org/0000-0002-1275-9802
Litinetskaya, Anastasia
Drost, Felix http://orcid.org/0000-0002-2600-4048
Zappia, Luke http://orcid.org/0000-0001-7744-8565
Lücken, Malte D. http://orcid.org/0000-0001-7464-7921
Strobl, Daniel C.
Henao, Juan
Curion, Fabiola http://orcid.org/0000-0003-2502-8803
Aliee, Hananeh
Ansari, Meshal
Badia-i-Mompel, Pau
Büttner, Maren
Dann, Emma
Dimitrov, Daniel
Dony, Leander
Frishberg, Amit
He, Dongze
Hediyeh-zadeh, Soroor
Hetzel, Leon
Ibarra, Ignacio L.
Jones, Matthew G.
Lotfollahi, Mohammad
Martens, Laura D.
Müller, Christian L.
Nitzan, Mor
Ostner, Johannes
Palla, Giovanni
Patro, Rob
Piran, Zoe
Ramírez-Suástegui, Ciro
Saez-Rodriguez, Julio
Sarkar, Hirak
Schubert, Benjamin
Sikkema, Lisa
Srivastava, Avi
Tanevski, Jovan
Virshup, Isaac
Weiler, Philipp
Schiller, Herbert B.
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
,
Article History
Accepted: 14 February 2023
First Online: 31 March 2023
Competing interests
: Main author list: M.D.L. has received speaker’s honoraria from Pfizer and Janssen, and received consulting fees from Chan-Zuckerberg Initiative. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Omniscope Ltd, and has ownership interest in Dermagnostix GmbH and Cellarity. M.G.J. consults for and has ownership interests in Vevo Therapeutics. L. Heumos has received speaker’s honorarium from Vesalius Therapeutics. Single-Cell Best Practices Consortium: M.G.J. consults for and has ownership interests in Vevo Therapeutics. R.P. is co-founder of Ocean Genomics, Inc. The other authors declare no competing interests.
Free to read: This content has been made available to all.